Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurement - Narrative (Details)

v3.22.2
Fair Value Measurement - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Fair Value Disclosures [Abstract]      
Impairment expense $ 57,500,000 $ 57,454,000 $ 0
Estimated fair value of DuraStim equipment $ 11,300,000 11,300,000  
Carrying value of DuraStim equipment   $ 68,800,000